Literature DB >> 14749284

The role of cytosolic phospholipase A(2) in insulin secretion.

Peter M Jones1, Christopher J Burns, Véronique D Belin, Helen M Roderigo-Milne, Shanta J Persaud.   

Abstract

Cytosolic phospholipase A(2) (cPLA(2)) comprises a widely expressed family of enzymes, some members of which have the properties required of signal transduction elements in electrically excitable cells. Thus, alpha- and beta-isoforms of cPLA(2) are activated by the increases in intracellular Ca(2+) concentration ([Ca(2+)](i)) achieved in depolarized cells. Activation is associated with a redistribution of the enzyme within the cell; activation of cPLA(2) generates arachidonic acid (AA), a biologically active unsaturated fatty acid that can be further metabolized to generate a plethora of biologically active molecules. Studies using relatively nonselective pharmacological inhibitors have implicated cPLA(2) in insulin secretory responses to stimuli that elevate beta-cell [Ca(2+)](i); therefore, we have investigated the role of cPLA(2) in beta-cell function by generating beta-cell lines that under- or overexpress the alpha-isoform of cPLA(2). The functional phenotype of the modified cells was assessed by observation of cellular ultrastructure, by measuring insulin gene expression and insulin protein content, and by measuring the effects of insulin secretagogues on cPLA(2) distribution, on changes in [Ca(2+)](i), and on the rate and pattern of insulin secretion. Our results suggest that cPLA(2) is not required for the initiation of insulin secretion from beta-cells, but that it plays an important role in the maintenance of beta-cell insulin stores. Our data also demonstrate that excessive production of, or exposure to, AA is deleterious to normal beta-cell secretory function through metabolic dysfunction.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14749284     DOI: 10.2337/diabetes.53.2007.s172

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  4 in total

1.  Group X secretory phospholipase A2 regulates insulin secretion through a cyclooxygenase-2-dependent mechanism.

Authors:  Preetha Shridas; Lubna Zahoor; Kathy J Forrest; Joseph D Layne; Nancy R Webb
Journal:  J Biol Chem       Date:  2014-08-13       Impact factor: 5.157

2.  The dual role of group V secretory phospholipase A2 in pancreatic β-cells.

Authors:  Preetha Shridas; Victoria P Noffsinger; Andrea C Trumbauer; Nancy R Webb
Journal:  Endocrine       Date:  2017-08-19       Impact factor: 3.633

3.  Inhibition of Ca2+-independent phospholipase A2 results in insufficient insulin secretion and impaired glucose tolerance.

Authors:  Keying Song; Xu Zhang; Chunying Zhao; Natasha T Ang; Zhongmin Alex Ma
Journal:  Mol Endocrinol       Date:  2004-10-07

4.  Drug repositioning for diabetes based on 'omics' data mining.

Authors:  Ming Zhang; Heng Luo; Zhengrui Xi; Ekaterina Rogaeva
Journal:  PLoS One       Date:  2015-05-06       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.